Lamivudine and Vth nerve injury - a phase IV clinical study of FDA data


Vth nerve injury is reported only by a few people who take Lamivudine.

The phase IV clinical study analyzes which people take Lamivudine and have Vth nerve injury. It is created by eHealthMe based on reports of 16,969 people who have side effects while taking Lamivudine from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

16,969 people reported to have side effects when taking Lamivudine.
Among them, 2 people (0.01%) have Vth nerve injury.

What is Lamivudine?

Lamivudine has active ingredients of lamivudine; zidovudine; nevirapine. It is often used in hiv infection. eHealthMe is studying from 17,011 Lamivudine users for its effectiveness, alternative drugs and more.

What is Vth nerve injury?

Vth nerve injury is found to be associated with 67 drugs and 34 conditions by eHealthMe.

Number of Lamivudine and Vth nerve injury reports submitted per year:

Could Lamivudine cause Vth nerve injury?

Gender of people who have Vth nerve injury when taking Lamivudine *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Vth nerve injury when taking Lamivudine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Lamivudine *:

  1. Darunavir: 2 people, 100.00%
  2. Tenofovir Disoproxil Fumarate: 1 person, 50.00%
  3. Ritonavir: 1 person, 50.00%
  4. Atazanavir: 1 person, 50.00%

Common side effects people have besides Vth nerve injury *:

  1. Viiith Nerve Injury: 2 people, 100.00%
  2. Pleocytosis (increased cell count): 2 people, 100.00%
  3. Pathogen Resistance: 2 people, 100.00%
  4. Motormental Retardation (a slowing-down of thought and a reduction of physical work): 2 people, 100.00%
  5. Hyperproteinaemia (a metabolic disorder characterized by enhanced plasma proline concentrations and urinary excretion): 2 people, 100.00%
  6. Facial Paralysis (loss of function of face muscle): 2 people, 100.00%
  7. Confusional State: 2 people, 100.00%
  8. Cerebellar Syndrome (impaired blood circulation to cerebellum due to lesion in artery): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lamivudine and have Vth nerve injury?

Check whether Vth nerve injury is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Vth nerve injury and when was it recovered:

Expand to all the drugs that have ingredients of lamivudine; zidovudine; nevirapine:

Alternative drugs to, pros and cons of Lamivudine:

Common Lamivudine side effects:

Browse all side effects of Lamivudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Vth nerve injury treatments and more:

COVID vaccines that are related to Vth nerve injury:

All the drugs that are associated with Vth nerve injury:

All the conditions that are associated with Vth nerve injury:

How the study uses the data?

The study uses data from the FDA. It is based on lamivudine; zidovudine; nevirapine (the active ingredients of Lamivudine) and Lamivudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: